The interferon-α regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors

Annals of Oncology

Volumn 11, Issue 6, 2000, Pages 707-714

  Zhou, Y ^a   Wang, S ^a   Gobl, A ^a   Oberg, K ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene expression; IRF 1 and IRF 2; P68; PKR; Signal transduction

Indexed keywords

ALPHA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; RECOMBINANT ALPHA2B INTERFERON; TRANSCRIPTION FACTOR;

ARTICLE; CANCER INHIBITION; CARCINOID; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

CARCINOID TUMOR; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON-ALPHA; PHOSPHOPROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033745653     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008314804492     Document Type: Article

References (29)

1. Regulation of the interferon system and cell growth by the IRF transcription factors
2. Transcription factors IRF-1 and IRF-2: Linking the immune responses and tumor suppression
3. Interferon regulatory factors: Growth control and histone gene regulation it's not just interferon anymore
4. Structurally similar but functionally distinct factors, IRF-1 and IRF- 2, bind to the same regulatory elements of IFN and IFN-inducible genes
5. IRF-1: The transcription factor linking the interferon response and oncogenesis
6. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs
7. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency
8. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression
9. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2
10. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
11. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer
12. Anti-oncogenic and oncogenic potentials of interferon regulatory factors 1 and 2
13. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
14. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
15. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-α in human hepatoma cell lines
16. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
17. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/Re1A fusion proteins
18. Apoptosis and carcinogenesis
19. The role of interferons in the management of carcinoid tumors
20. Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours
21. The action of interferon alpha on human carcinoid tumours
22. Expression of p68 protein kinase and its prognostic significance during IFN-α therapy in patients with carcinoid tumours
23. Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-α in carcinoid tumor cells
24. Targeted disruption of the mouse phospholipase C beta3 gene results in early embryonic lethality
25. Prognostic role of urokinase-type plasminogen activator in human gliomas
26. Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice
27. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes
28. Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis
29. Activation of a cell-cycle-regulated historic gene by the oncogenic transcription factor IRF-2